You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cilastatin

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Tract Infection, Acute Pyelonephritis Trial (TBP-PI-HBr, Imipenem-cilastatin, Dummy Infusion)

Not yet recruiting
  • Urinary Tract Infection
  • Acute Pyelonephritis
  • (no location specified)
Sep 22, 2023

Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Meegomäe (co-administration of cefepime and nacubactam,

Recruiting
  • Complicated Urinary Tract Infection
  • Acute Pyelonephritis
  • co-administration of cefepime and nacubactam
  • +2 more
  • Meegomäe, Voru, Estonia
    Meiji Research Site
May 24, 2023

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia Trial (Combination of Imipenem/Cilastatin and

Not yet recruiting
  • Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
  • (no location specified)
Feb 2, 2022

Cystic Fibrosis, Pneumonia, Bacterial Trial in United States (Imipenem/Cilastatin/Relebactam)

Recruiting
  • Cystic Fibrosis
  • Pneumonia, Bacterial
  • Hartford, Connecticut
  • +6 more
Jan 3, 2023

Bacterial Infections Trial in Miami, Orlando (XNW4107, Imipenem/Cilastatin)

Active, not recruiting
  • Bacterial Infections
  • XNW4107, Imipenem/Cilastatin
  • Miami, Florida
  • +1 more
Jan 5, 2022

Bacterial Infections Trial in Phoenix (XNW4107, Imipenem/Cilastatin)

Completed
  • Bacterial Infections
  • XNW4107, Imipenem/Cilastatin
  • Phoenix, Arizona
    Pulmonary Associates PA
Jan 5, 2022

Complicated Urinary Tract Infection Including Acute Pyelonephritis Trial (Combination of Imipenem/Cilastatin and XNW4107,

Not yet recruiting
  • Complicated Urinary Tract Infection Including Acute Pyelonephritis
  • Combination of Imipenem/Cilastatin and XNW4107
  • Meropenem
  • (no location specified)
Feb 2, 2022

Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections Trial in Charlotte

Recruiting
  • Carbapenem-Resistant Enterobacteriaceae Infection
  • +3 more
  • Charlotte, North Carolina
    Carolinas Medical Center
Jun 16, 2022

Bacterial Infections Trial in Baltimore (XNW4107)

Completed
  • Bacterial Infections
  • Baltimore, Maryland
    Pharmaron CPC
Jan 4, 2022

Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) Trial (HRS -8427, Imipenem and

Not yet recruiting
  • Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
  • HRS -8427
  • Imipenem and Cilastatin Sodium
  • (no location specified)
Nov 16, 2023

Obesity, Critical Illness Trial in Chicago (Imipenem/Cilastatin/Relebactam 1.25g)

Enrolling by invitation
  • Obesity
  • Critical Illness
  • Imipenem/Cilastatin/Relebactam 1.25g
  • Chicago, Illinois
    University of Illinois at Chicago
May 18, 2022

Bacterial Infections Trial in Orlando (XNW4107, Imipenem/Cilastatin, )

Active, not recruiting
  • Bacterial Infections
  • Orlando, Florida
    Orlando Clinical Research Center (OCRC)
Jan 5, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2022

Bacterial Pneumonia Trial (Imipenem, Relebactam, Cilastatin)

Completed
Has Results
  • Bacterial Pneumonia
  • (no location specified)
Apr 3, 2020

Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection Trial in Japan (Imipenem+Cilastatin/Relebactam)

Completed
Has Results
  • Complicated Intra-abdominal Infection
  • Complicated Urinary Tract Infection
  • Nagoya, Aichi, Japan
  • +28 more
Jan 20, 2021

Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia Trial in Worldwide (IMI/REL FDC, PIP/TAZ FDC,

Completed
  • Hospital-Acquired Bacterial Pneumonia
  • Ventilator-Associated Bacterial Pneumonia
  • IMI/REL FDC
  • +2 more
  • Belo Horizonte, Minas Gerais, Brazil
  • +67 more
Jul 19, 2022

Infectious Disease Trial (MK-7655, Imipenem + Cilastatin, Caffeine)

Completed
Has Results
  • Infectious Disease
  • (no location specified)
May 28, 2020

Urinary Tract Infections Trial (Cefiderocol, Imipenem/cilastatin)

Completed
Has Results
  • Urinary Tract Infections
  • (no location specified)
Nov 20, 2019

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Unknown status
  • Critical Illness
  • Bacterial Infections
  • Hat Yai, Songkla, Thailand
    Faculty of Medicine, Prince of Songkla University, Thailand
Apr 28, 2020

Intra-abdominal Infections Trial (Relebactam 250 mg, Relebactam 125 mg, Imipenem/cilastatin)

Completed
Has Results
  • Intra-abdominal Infections
  • Relebactam 250 mg
  • +3 more
  • (no location specified)
Jun 7, 2019

Urinary Tract Infections, Pyelonephritis Trial (Relebactam 250 mg, Relebactam 125 mg, imipenem/cilastatin 500 mg)

Completed
Has Results
  • Urinary Tract Infections
  • Pyelonephritis
  • Relebactam 250 mg
  • +4 more
  • (no location specified)
Apr 26, 2019

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL, Active Control)

Recruiting
  • Suspected or Documented Gram-negative Bacterial Infection
  • Tucson, Arizona
  • +64 more
Aug 18, 2022

Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)

Terminated
  • Osteomyelitis
  • oral antibiotics
  • intravenous antibiotics
  • Louisville, Kentucky
    University of Louisville
Apr 2, 2021

Febrile Neutropenia, Hematological Malignancy Trial in Amsterdam, The Hague (Discontinuation of imipenem-cilastatin or

Completed
  • Febrile Neutropenia
  • Hematological Malignancy
  • Discontinuation of imipenem-cilastatin or meropenem
  • Amsterdam, Netherlands
  • +1 more
Sep 23, 2019

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL FDC)

Completed
Has Results
  • Suspected or Documented Gram-negative Bacterial Infection
  • IMI/REL FDC
  • Little Rock, Arkansas
  • +32 more
Oct 28, 2021